Atmo Biosciences is a Melbourne-based digital health company focused on the development of ingestible gas-sensing capsules. The company's primary product is a swallowable capsule that collects high-resolution, real-time data on gut gasses, which can be used to diagnose digestive disorders and monitor the effectiveness of dietary changes.

The company was established in 2018 and since then, it has been focused on improving the detection and management of gastrointestinal disorders. Atmo Biosciences' unique approach to gut health has the potential to significantly improve the way gastrointestinal diseases are diagnosed and treated, providing patients with a non-invasive, clinically validated alternative to traditional methods.

Connect